FGA
GILD icon

Fortis Group Advisors’s Gilead Sciences GILD Stock Holding History

Fortis Group Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.1K Hold
246
– – 0.01% 320
2026
Q1 		$34.3K Hold
246
– – 0.01% 321
2025
Q4 		$30.2K Hold
246
– – 0.01% 321
2025
Q3 		$27.3K Hold
246
– – ﹤0.01% 279
2025
Q2 		$27.3K Hold
246
– – 0.01% 270
2025
Q1 		$27.6K Hold
246
– – 0.01% 240
2024
Q4 		$22.7K Hold
246
– – ﹤0.01% 247
2024
Q3 		$20.6K Hold
246
– – ﹤0.01% 241
2024
Q2 		$16.9K Hold
246
– – ﹤0.01% 247
2024
Q1 		$18K Sell
246
-246
-50% -$18.9K ﹤0.01% 265
2023
Q4 		$39.9K Buy
492
+246
+100% +$19.1K 0.01% 181
2023
Q3 		$18.4K Buy
+246
New +$18.9K 0.01% 181
2020
Q3 		$15K Buy
+246
New +$17.1K ﹤0.01% 259

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fortis Group Advisors's GILD Position: Q2 2026 in Review

Fortis Group Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 246 shares worth $31.1K. The position accounts for 0.01% of the portfolio, ranked #320.

Fortis Group Advisors first reported a position in GILD in Q3 2020 and has held it in 13 quarters since. The position peaked at $39.9K in Q4 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fortis Group Advisors held 246 shares of Gilead Sciences worth $31.1K as of Q2 2026.
  • Fortis Group Advisors left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Fortis Group Advisors's portfolio in Q2 2026, its #320 holding.
  • Fortis Group Advisors first reported a position in Gilead Sciences in Q3 2020 and has held it in 13 quarters since.
  • Fortis Group Advisors's Gilead Sciences position peaked at $39.9K in Q4 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.